AAAAAA

   
Results: 1-16 |
Results: 16
VASCULAR ACCESS PROBLEMS REVISITED - THE MULTINATIONAL ASSOCIATION OFSUPPORTIVE CARE IN CANCER (MASCC) EXPERIENCE
Authors: FREYTES CO
Citation: Co. Freytes, VASCULAR ACCESS PROBLEMS REVISITED - THE MULTINATIONAL ASSOCIATION OFSUPPORTIVE CARE IN CANCER (MASCC) EXPERIENCE, Supportive care in cancer, 6(1), 1998, pp. 13-19
ANTITUMOR-ACTIVITY OF DAB(389)IL-2 FUSION TOXIN IN MYCOSIS-FUNGOIDES
Authors: SALEH MN LEMAISTRE CF KUZEL TM FOSS F PLATANIAS LC SCHWARTZ G RATAIN M ROOK A FREYTES CO CRAIG F REUBEN J SAMS MW NICHOLS JC
Citation: Mn. Saleh et al., ANTITUMOR-ACTIVITY OF DAB(389)IL-2 FUSION TOXIN IN MYCOSIS-FUNGOIDES, Journal of the American Academy of Dermatology, 39(1), 1998, pp. 63-73
PHASE-I TRIAL OF A LIGAND FUSION-PROTEIN (DAB(389)IL-2) IN LYMPHOMAS EXPRESSING THE RECEPTOR FOR INTERLEUKIN-2
Authors: LEMAISTRE CF SALEH MN KUZEL TM FOSS F PLATANIAS LC SCHWARTZ G RATAIN M ROOK A FREYTES CO CRAIG F REUBEN J NICHOLS JC
Citation: Cf. Lemaistre et al., PHASE-I TRIAL OF A LIGAND FUSION-PROTEIN (DAB(389)IL-2) IN LYMPHOMAS EXPRESSING THE RECEPTOR FOR INTERLEUKIN-2, Blood, 91(2), 1998, pp. 399-405
VASCULAR ACCESS DEVICES IN CANCER-PATIENTS - TOWARDS THE NEXT STEP
Authors: FREYTES CO
Citation: Co. Freytes, VASCULAR ACCESS DEVICES IN CANCER-PATIENTS - TOWARDS THE NEXT STEP, European journal of cancer, 33(8), 1997, pp. 1171-1172
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT FOR BREAST-CANCER IN NORTH-AMERICA
Authors: ANTMAN KH ROWLINGS PA VAUGHAN WP PELZ CJ FAY JW FIELDS KK FREYTES CO GALE RP HILLNER BE HOLLAND HK KENNEDY MJ KLEIN JP LAZARUS HM MCCARTHY PL SAEZ R SPITZER G STADTMAUER EA WILLIAMS SF WOLFF S SOBOCINSKI KA ARMITAGE JO HOROWITZ MM
Citation: Kh. Antman et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT FOR BREAST-CANCER IN NORTH-AMERICA, Journal of clinical oncology, 15(5), 1997, pp. 1870-1879
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION
Authors: TSAI T GOODMAN S SAEZ R SCHILLER G ADKINS D CALLANDER N WOLFF S FREYTES CO
Citation: T. Tsai et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION, Bone marrow transplantation, 20(10), 1997, pp. 859-863
COKEROMYCES RECURVATUS INFECTION IN A BONE-MARROW TRANSPLANT RECIPIENT
Authors: TSAI TW HAMMOND LA RINALDI M MARTIN K TIO F MAPLES J FREYTES CO ROODMAN GD
Citation: Tw. Tsai et al., COKEROMYCES RECURVATUS INFECTION IN A BONE-MARROW TRANSPLANT RECIPIENT, Bone marrow transplantation, 19(3), 1997, pp. 301-302
AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSISLOW-GRADE LYMPHOMA
Authors: FREYTES CO VUKELJA S SALZMAN D TSAI T CALLANDER N GOKMEN E RODRIGUEZ T CASTRO J BOLDT D ROODMAN GD HILSENBECK S ADKINS D BACHIER C CRAIG F CLARE N WEISNER A LEMAISTRE CF
Citation: Co. Freytes et al., AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSISLOW-GRADE LYMPHOMA, Experimental hematology, 24(9), 1996, pp. 629-629
REPRESENTATION OF HISPANICS IN THE NATIONAL MARROW DONOR PROGRAM
Authors: FREYTES CO BEATTY PG
Citation: Co. Freytes et Pg. Beatty, REPRESENTATION OF HISPANICS IN THE NATIONAL MARROW DONOR PROGRAM, Bone marrow transplantation, 17(3), 1996, pp. 323-327
HEMOLYSIS DUE TO ANTI-A IN A RECIPIENT OF A MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANT IN PRESENCE OF A NEGATIVE DIRECT ANTIGLOBULIN-TEST
Authors: GRIFFITHS E TEAGUE J HARRISON CR FREYTES CO
Citation: E. Griffiths et al., HEMOLYSIS DUE TO ANTI-A IN A RECIPIENT OF A MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANT IN PRESENCE OF A NEGATIVE DIRECT ANTIGLOBULIN-TEST, Blood, 88(10), 1996, pp. 3746-3746
QUANTITATIVE ASSESSMENT OF MYELOMA PERIPHERAL-BLOOD AND BONE-MARROW TUMOR BURDEN IN PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION
Authors: VESCIO RA SCHILLER GJ STEWART AK ANDERSON KC DIPERSIO JF NOGA SJ BALLESTER OF RUGO H FREYTES CO WU CH HAN EJ CAO J BELSON DJ BERENSON JR
Citation: Ra. Vescio et al., QUANTITATIVE ASSESSMENT OF MYELOMA PERIPHERAL-BLOOD AND BONE-MARROW TUMOR BURDEN IN PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION, Blood, 88(10), 1996, pp. 2551-2551
AUGMENTED CYCLOPHOSPHAMIDE (C), CARMUSTINE (B) AND ETOPOSIDE (V) + - DACARBAZINE (D) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - LOWER PERITRANSPLANT MORTALITY AND ANALYSIS OF PROGNOSTIC FACTORS/
Authors: TSAI T SALZMAN D CLARK G CASTRO J CALLANDER N BOLDT D ROODMAN GD SHERIDANLEOS N WIESNER A ADKINS D HARRIS K RODRIGUEZ T GOKMEN E LEMAISTRE CF FREYTES CO
Citation: T. Tsai et al., AUGMENTED CYCLOPHOSPHAMIDE (C), CARMUSTINE (B) AND ETOPOSIDE (V) + - DACARBAZINE (D) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - LOWER PERITRANSPLANT MORTALITY AND ANALYSIS OF PROGNOSTIC FACTORS/, Blood, 86(10), 1995, pp. 3865-3865
PHASE-I TRIAL OF DACARBAZINE WITH CYCLOPHOSPHAMIDE, CARMUSTINE, ETOPOSIDE, AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MULTIPLE-MYELOMA
Authors: ADKINS DR SALZMAN D BOLDT D KUHN J IRVIN R ROODMAN GD LYONS R SMITH L FREYTES CO LEMAISTRE CF
Citation: Dr. Adkins et al., PHASE-I TRIAL OF DACARBAZINE WITH CYCLOPHOSPHAMIDE, CARMUSTINE, ETOPOSIDE, AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MULTIPLE-MYELOMA, Journal of clinical oncology, 12(9), 1994, pp. 1890-1901
BONE-MARROW TRANSPLANTATION (BMT) FOR ADULT POOR-RISK HIGH-GRADE NON-HODGKINS-LYMPHOMA (HGNHL)
Authors: BACHIER C FREYTES CO SALZMAN D CASTRO J BOLDT D ROODMAN GD HARRIS K CRAIG F WIESNER A LEMAISTRE CF
Citation: C. Bachier et al., BONE-MARROW TRANSPLANTATION (BMT) FOR ADULT POOR-RISK HIGH-GRADE NON-HODGKINS-LYMPHOMA (HGNHL), Blood, 84(10), 1994, pp. 10000703-10000703
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE IN RESISTANT OR RECURRENT LOW-GRADE LYMPHOMA
Authors: FREYTES CO BACHIER C SALZMAN D VUKELIA S CASTRO J BOLDT D ROODMAN GD CRAIG F HARRIS K TSAI T SHERIDANLEOS N HILSENBECK S TAMI J BURRELL L LEMAISTRE CF
Citation: Co. Freytes et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE IN RESISTANT OR RECURRENT LOW-GRADE LYMPHOMA, Blood, 84(10), 1994, pp. 10000709-10000709
HIGH-DOSE CHEMOTHERAPY WITH STEM-CELL RESCUE IN OLDER PATIENTS
Authors: FREYTES CO SALZMAN DE BACHIER C BOLDT DH ROODMAN GD CRAIG F CASTRO J LEMAISTRE CF
Citation: Co. Freytes et al., HIGH-DOSE CHEMOTHERAPY WITH STEM-CELL RESCUE IN OLDER PATIENTS, Blood, 82(10), 1993, pp. 10000173-10000173
Risultati: 1-16 |